Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Global X Genomics & Biotechnology ETF (NQ:GNOM)

42.78 -0.20 (-0.47%)

Streaming Delayed Price Updated: 1:27 PM EDT, Mar 19, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	59,912
Open	42.65
Bid (Size)	42.73 (200)
Ask (Size)	42.78 (100)
Prev. Close	42.98
Today's Range	42.45 - 43.12
52wk Range	27.20 - 51.42
Shares Outstanding	33,418,720
Dividend Yield	2.76%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Is CRSP Stock Falling Pre-Market Today? ↗

March 10, 2026

The company plans to issue $350 million in convertible senior notes that are scheduled to mature in 2031.

Via Stocktwits

Why Did BNTX Stock Tumble 17% Pre-Market Today? ↗

March 10, 2026

BioNTech co-founders Ugur Sahin and Özlem Türeci are set to leave the company to head the new venture.

Via Stocktwits

Performance

YTD	-6.3%	-6.3%
1 Month	-7.6%	-7.6%
3 Month	-6.2%	-6.2%
6 Month	+16.4%	+16.4%
1 Year	+23.1%	+23.1%

More News

Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review ↗

February 18, 2026

Via Stocktwits

Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance ↗

April 07, 2025

Via Benzinga

ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play? ↗

June 04, 2021

Via Talk Markets

3 Gene Editing Stocks with Potential to Transform Medicine ↗

August 09, 2024

Via InvestorPlace

The 3 Best Gene Editing Stocks to Buy in July 2024 ↗

July 08, 2024

Via InvestorPlace

Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗

May 10, 2024

Via InvestorPlace

3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗

May 02, 2024

Via InvestorPlace

3 Stocks That Could Be the Next Big Thing in Gene Editing ↗

March 21, 2024

Via InvestorPlace

3 Gene Editing Stocks With Unprecedented Surge Potential ↗

February 13, 2024

Via InvestorPlace

3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential ↗

January 31, 2024

Via InvestorPlace

3 Gene Editing Stocks to Generate Super-Charged Gains ↗

October 18, 2023

Via InvestorPlace

The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗

March 25, 2023

Via InvestorPlace

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

Via InvestorPlace

3 Gene Editing Stocks With the Best Long-Term Potential ↗

January 25, 2023

Via InvestorPlace

3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years ↗

January 18, 2023

Via InvestorPlace

ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM ↗

October 21, 2021

Via Talk Markets

A Comprehensive Guide To Genomic ETFs ↗

July 11, 2021

Via Talk Markets

Top-Performing Biotech ETFs of Last Week ↗

June 14, 2021

Via Talk Markets

Frequently Asked Questions

Is Global X Genomics & Biotechnology ETF publicly traded?

Yes, Global X Genomics & Biotechnology ETF is publicly traded.

What exchange does Global X Genomics & Biotechnology ETF trade on?

Global X Genomics & Biotechnology ETF trades on the Nasdaq Stock Market

What is the ticker symbol for Global X Genomics & Biotechnology ETF?

The ticker symbol for Global X Genomics & Biotechnology ETF is GNOM on the Nasdaq Stock Market

What is the current price of Global X Genomics & Biotechnology ETF?

The current price of Global X Genomics & Biotechnology ETF is 42.78

When was Global X Genomics & Biotechnology ETF last traded?

The last trade of Global X Genomics & Biotechnology ETF was at 03/19/26 01:27 PM ET

What is the market capitalization of Global X Genomics & Biotechnology ETF?

The market capitalization of Global X Genomics & Biotechnology ETF is 1.43B

How many shares of Global X Genomics & Biotechnology ETF are outstanding?

Global X Genomics & Biotechnology ETF has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.